临床试验/NCT02556489

NCT02556489已完成不适用

Transcriptomics Signature of Anti Vaccinia Memory B Cells in Healthy Individuals at a Short Time After Vaccination

Institut National de la Santé Et de la Recherche Médicale, France1 个研究点分布在 1 个国家目标入组 4 人开始时间: 2015年11月3日最近更新: 2026年6月8日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 4
试验地点: 1
主要终点: signature of anti vaccinia long-lived memory B cells

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Analyse the transcriptomic signature of anti vaccinia memory B cells at a short time after vaccination as compared to the signature already established in long-lived memory B cells.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 20 Years 至 50 Years（Adult）
性别: All
接受健康志愿者: 是

入选标准

•Healthy donors vaccinated against smallpox

排除标准

未提供

结局指标

主要结局

signature of anti vaccinia long-lived memory B cells

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方

Institut National de la Santé Et de la Recherche Médicale, France

申办方类型

Other Gov

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

Unknown

4 期

B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic IndividualsAspleniaβ-thalassemia Major

NCT01846923Aghia Sophia Children's Hospital of Athens37

已完成

4 期

Immunologic Memory (Supp. of ATN 024)HIV Infections

NCT00142753University of North Carolina, Chapel Hill95

已完成

4 期

Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.Hepatitis B

NCT00456625GlaxoSmithKline76

进行中（未招募）

不适用

B-cell memory and humoral immune response after primary immunization against tick borne encephalitis (TBE) in the elderly - Vaccine-induced immunity against TBE in the elderlyThis study will investigate immunity against tick-borne encephalitis (TBE) following primary TBE vaccination in healthy volunteers 18-30 years or > 60 years who fulfill the local criteria for TBE vaccination (tick exposure possible).MedDRA version: 9.1Level: LLTClassification code 10036897Term: Prophylactic vaccination

EUCTR2007-005645-38-ATClinical Institute of Virology, Medical University of Vienna

已完成

2 期

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy ToddlersInfections, Meningococcal

NCT00135564GlaxoSmithKline500